ReviewNutrients2026
Perioperative Immunonutrition for Elective Surgery: Review of Mechanisms, Summary of Evidence, and Future Directions.
Review in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surgical trauma triggers a complex metabolic and inflammatory response that can profoundly affect patient recovery and clinical outcomes. The magnitude of this stress response correlates with surgical complexity, patient comorbidities, and baseline nutritional status. Immunonutrition refers to the strategic use of specific nutrients, including arginine, glutamine, omega-3 polyunsaturated fatty acids, and nucleotides, to modulate immune and inflammatory responses beyond their basic nutritional value. These pharmaconutrients possess distinct immunomodulatory properties that may attenuate surgical stress responses, enhance immune function, and improve clinical outcomes. While numerous randomized controlled trials and meta-analyses have been conducted over the past several decades, significant methodological heterogeneity, variable product compositions, inconsistent administration protocols, and divergent patient populations complicate the interpretation of findings. Recent well-designed investigator-initiated trials without industry funding have failed to demonstrate benefits, raising questions about the validity of earlier positive findings and challenging current guideline recommendations. The evidence base reveals promising signals of benefit in selected populations combined with substantial limitations. Available evidence suggests that immunonutrition may be most beneficial in severely malnourished patients undergoing major gastrointestinal surgery, particularly when administered perioperatively or postoperatively, though the certainty of this evidence remains moderate at best, given the methodological limitations in the existing literature. From an economic perspective, immunonutrition may represent a dominant intervention in appropriate patient populations, though cost-effectiveness estimates derive primarily from older studies with methodological limitations. However, focus on specialized immunonutrition should not distract from fundamental perioperative nutritional care, including systematic risk screening, optimization when feasible, early postoperative feeding, and achievement of adequate protein and calorie targets. Only through methodologically rigorous research addressing fundamental questions can the promise of perioperative immunonutrition be fully realized.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.